Home » Topics » BioWorld

BioWorld
RSS

BIOTECH STOCKS CONTINUE TO TUMBLE

Feb. 9, 1993

OXIGENE RAISES $2.3 MILLION TO FUND LUNG CANCER TRIALS

Feb. 9, 1993

GTI UNDERWRITERS EXERCISE OVERALLOTMENT OPTION

Feb. 9, 1993

NEOSE LICENSES CARBOHYDRATE SYNTHESIS TECHNOLOGY

Feb. 9, 1993

CANCER IMAGING MABS ENTER CLINIC

Feb. 9, 1993

GLIATECH GETS SBIR GRANT TO STUDY ALZHEIMER'S LESIONS

Feb. 9, 1993

FIRM CORNERS PATENTS FOR FREEZE-DRIED BLOOD

Feb. 9, 1993

CEPRATE USED TO PURIFY STEM CELLS

Feb. 8, 1993

AT BIOCHEM CHANGES NAME

Feb. 8, 1993

CALGENE SUES ENZO IN ANTISENSE DISPUTE

Feb. 8, 1993

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...